Based on these data, we aimed to investigate the role of TIM-3 on metabolic reprogramming in AML cells by using two AML cell lines, HL-60 and THP-1, representing M3 and M5 AML subtypes, respectively.1 This evidence concerns the gene HAVCR2 and acute myeloid leukemia.